bf/NASDAQ:ATXS_icon.jpeg

COM:ASTRIATX

Astria Therapeutics

  • Stock

Last Close

9.58

21/11 16:08

Market Cap

572.19M

Beta: -

Volume Today

25.38K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology
  • website

    astriatx.com
  • ipo date

    Jun 25, 2015

Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage for the treatment of hereditary ...Show More

investor of

competitor of